We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest

By HospiMedica International staff writers
Posted on 13 Apr 2022
Print article
Image: ASSURE WCD system was one of the winners of the 2022 Medical Design Excellence Awards (Photo courtesy of Kestra Medical)
Image: ASSURE WCD system was one of the winners of the 2022 Medical Design Excellence Awards (Photo courtesy of Kestra Medical)

Sudden cardiac arrest is a leading cause of death. SCA is an abrupt cessation of the normal heartbeat that is triggered by an electrical malfunction in the heart, typically caused by ventricular arrhythmias. It can lead to a loss of consciousness and potentially death within minutes if not treated. Heart failure (HF) patients and patients with low left ventricular ejection fraction (low LVEF) of 35% or below are at elevated risk of SCA while waiting for their condition to improve or until eligible for subsequent therapy. Wearable Cardioverter Defibrillators (WCDs) are non-invasive, monitor around the clock, and can protect patients who are at known risk for SCA

The ASSURE system from Kestra Medical Technologies (Kirkland, WA, USA) represents the next generation of monitoring and therapy to protect patients at risk of SCA. It includes a wearable device that provides autonomous detection and defibrillation for ventricular arrhythmias, if needed. The complete Cardiac Recovery System includes the ASSURE WCD, the ASSURE patient app, and Kestra CareStation remote patient data platform, all working together to provide comfortable protection for patients and clear insights for providers. The ASSURE WCD system received Food and Drug Administration premarket approval in 2021 and was also recognized as one of the winners of the 2022 Medical Design Excellence Awards (MDEA).

Related Links:
Kestra Medical Technologies 

Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Bronchoscope
EB-500

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more